Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives

AIDS

Volumn 17, Issue 2, 2003, Pages 177-181

  Vicenzi, Elisa ^a,c   Gatti, Alessandra ^a   Ghezzi, Silvia ^a   Oreste, Pasqua ^b   Zoppetti, Giorgio ^b   Poli, Guido ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Glycores 2000 Srl   (Italy)

^c P2 P3 Laboratories   (Italy)

Author keywords

Co receptors; HIV; K5 polysaccharide; Polyanions; Primary isolates; Viral entry

Indexed keywords

ANTIRETROVIRUS AGENT; BACTERIAL POLYSACCHARIDE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; POLYSACCHARIDE SULFATE;

ARTICLE; CELL LINE; CHEMICAL STRUCTURE; CYTOTOXICITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SULFATION; T LYMPHOBLAST; VIRUS ADSORPTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CELLS, CULTURED; ESCHERICHIA COLI; GIANT CELLS; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGES; POLYSACCHARIDES, BACTERIAL; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECEPTORS, VIRUS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 0037462631     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200301240-00006     Document Type: Article

References (27)

1. Moore JP, Stevenson M. New targets for inhibitors of HIV-1 replication. Nature Rev Mol Cell Biol 2000, 1:40-49.
2. Haywood AM. Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol 1994, 68:1-5.
3. Mondor I, Ugolini S, Sattentau QJ. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J Virol 1998, 72:3623-3634.
4. Saphire AC, Bobardt MD, Gallay PA. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO J 1999, 18:6771-6785.
5. Saphire AC, Bobardt MD, Zhang Z, David G, Gallay PA. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J Virol 2001, 75:9187-9200.
6. Batinic D, Robey F. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J Biol Chem 1992, 267:6664-6667.
7. Callahan L, Phelan M, Mallinson M, Norcross M. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions. J Virol 1991, 65:1543-1550.
8. Harrop HA, Coombe DR, Rider CC. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding. AIDS 1994, 8:183-192.
9. Rider CC, Coombe DR, Harrop HA, Hounsell EF, Bauer C, Feeney J, et al. Anti-HIV-1 activity of chemically modified heparins: correlation between binding to the V3 loop of gp120 and inhibition of cellular HIV- 1 infection in vitro. Biochemistry 1994, 33:6974-6980.
10. Roderiquez G, Oravecz T, Yanagishita M, Bou-Habib DC, Mostowski H, Norcross MA. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J Virol 1995, 69:2233-2239.
11. Harrop HA, Rider CC. Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4. Glycobiology 1998, 8:131-137.
12. Witvrouw M, De Clercq E. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen Pharmacol 1997, 29:497-511.
13. Vann WF, Schmidt MA, Jann B, Jann K. The structure of the capsular polysaccharide (K5 antigen) of urinary tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. Eur J Biochem 1981, 116:359-364.
14. Leali D, Belleri M, Urbinati C, Coltrini D, Oreste P, Zoppetti G, et al. Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. J Biol Chem 2001, 276:37900-37908.
15. Ghezzi S, Menzo S, Brambilla A, Bordignon PP, Lorini AL, Clementi M, et al. Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands. Virology 2001, 280:253-261.
16. Cota M, Kleinschmidt A, Ceccherini-Silberstein F, Aloisi F, Mengozzi M, Mantovani A, et al. Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1. J Neurovirol 2000, 6:75-83.
17. Labrosse B, Brelot A, Heveker N, Sol N, Schols D, De Clercq E, et al. Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100. J Virol 1998, 72:6381-6388.
18. Eustice DC, Feldman PA, Colberg-Poley AM, Buckery RM, Neubauer RH. A sensitive method for the detection of beta-galactosidase in transfected mammalian cells. Biotechniques 1991, 11:739-743.
19. Meylan PR, Kornbluth RS, Zbinden I, Richman DD. Influence of host cell type and V3 loop of the surface glycoprotein on susceptibility of human immunodeficiency virus type 1 to polyanion compounds. Antimicrob Agents Chemother 1994, 38:2910-2916.
20. Trouplin V, Salvatori F, Cappello F, Obry V, Brelot A, Heveker N, et al. Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay. J Virol 2001, 75:251-259.
21. Folks TM, Powell D, Lightfoote M, Koenig S, Fauci AS, Benn S, et al. Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med 1986, 164:280-290.
22. Vicenzi E, Poli G. Regulation of HIV expression by viral genes and cytokines. J Leukoc Biol 1994, 56:328-334.
23. Moulard M, Lortat-Jacob H, Mondor I, Roca G, Wyatt R, Sodroski J, et al. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J Virol 2000, 74:1948-1960.
24. Ylisastigui L, Bakri Y, Amzazi S, Gluckman JC, Benjouad A. Soluble glycosaminoglycans do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1. Virology 2000, 278:412-422.
25. Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science 1997, 276:1857-1861.
26. Luscher-Mattli M. Polyanions-a lost chance in the fight against HIV and other virus diseases? Antivir Chem Chemother 2000, 11:249-259.
27. Shattock RJ, Doms RW. AIDS models: microbicides could learn from vaccines. Nature Med 2002, 8:425.